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Sensitization to inhalant allergens commonly commences in utero, and most children are born
with weak T helper-2 (Th2)-polarized T-cell immunity to these agents. During early life, these
responses are normally deviated toward the Thl cytokine profile. However, in atopics this
immune deviation process fails, leading instead to consolidation of allergen-specific Th2 immunity
and its eventual active expression in the airways. Both the induction and expression of Th2
immunity can be modulated by environmental agents that affect the cytokine milieu in the airway
mucosa and/or the draining lymph nodes. Because of the known effects of the mold cell wall
component (1-*3)-P-D-glucan on monocyte cytokine secretion, exposure to molds during
childhood may be a significant etiologic factor in allergic respiratory disease in general. Key
words: atopy, (1-3)--Do-glucan, LPS, molds, T-helper cells. - Environ Health Perspect 107(suppl
3):485-487 (1999).
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It is generally accepted that the develop-
ment of the immune system in children is
sensitive to environmental agents. In par-
ticular, growing evidence indicates that the
development of immunity to inhaled anti-
gens can be influenced by coexposure to
airborne irritants, which can influence the
functions of bone marrow-derived cells.
There is also indirect evidence from human
epidemiologic studies (1) that exposure of
school children to molds can exacerbate
atopic symptoms.
This article describes a working model
for the interaction between the environ-
ment and immune function in children
and illustrates how exposure to molds
could be a significant modifying factor.
Immunologic Features ofthe
Natural History ofAllergic
Respiratory Disease
Aliergen-Specific Immunity inAdults
It is now generally accepted that active
T-cell immunity against common inhalant
allergens is universal among adults, and
allergen responder phenotype is determined
by the nature ofthe cytokines produced by
allergen-specific T helper (Th) memory
cells at each exposure (2,3). Thus, if the
dominant Th cells in respective memory
populations produce the Th2 pattern of
cytokines (especially interleukin [ILJ-4 and
IL-5), exposure will potentially trigger IgE
production and eosinophilia, and hence
allergic symptoms, as in atopics. In con-
trast, if the dominant Th-cell populations
produce only low levels ofThl cytokines
(IL-2 and IFNy), allergen exposure will
result in only moderate IgG and IgA anti-
body production and no symptoms.
Additionally, the expression of Thl
immunity actively inhibits Th2 responses
via antagonistic effects of IFNy upon Th2
cell growth.
Initial PrimingofAllergen-Specific
Th MemoryCells
Recent evidence from a number of labora-
tories [reviewed in Holt and Macaubas
(4)] indicates that the process is normally
initiated in utero via transplacental leakage
of extremely low levels of allergens to
which the mother is exposed during preg-
nancy. This low-level stimulation occurs at
a time during which placentally derived
factors including cytokines, prostaglandins,
and hormones are actively inhibiting all
forms ofThl immunity at the fetomater-
nal interface to protect the placenta against
the toxic effects of IFNy (5, 6). These ini-
tial fetal responses are thus polarized
toward the Th2 cytokine profile (7,8).
Postnatal Modulation of
FetallyPrimedAllergen-Specific
Th Cell Responses
After birth, the newborn immune
system encounters high levels of inhalant
allergens from the environment and these
repeated cycles of Th-cell stimulation
shape the nature of developing Th
memory populations.
In normal (nonatopic) children, these
early Th2 responses are progressively con-
verted to Thl via a process known as
immune deviation (4,6), and Th memory
patterns similar to those of adults are seen
by approximately 5 years of age (9).
However, for reasons not yet fully under-
stood, this immune deviation process fre-
quently fails in children with atopic family
history, leading instead to consolidation of
allergen-specific Th2 immunity, and hence
heightened risk for allergy (9). This may
be due in part to a transient maturational
defect in ThI function in atopics (4,6).
Induction Versus Expression
ofAllergen-Specific
Th2 Immunity
Inhalant allergen-specific Th2 immunity
per se does not automatically lead to aller-
gic respiratory disease, as demonstrated in a
variety of epidemiologic studies. Up to
40% of preteen school children are Th2
responsive to one or more inhalants, but
only one-quarter ofthese go on to develop
bronchial hyperresponsiveness (BHR) and
persistent wheeze; the latter proportion
increases only to approximately one-third
by adulthood. However, more than 90%
of both children and adults who express
BHR are atopic, indicating that atopy is
necessary but not sufficient for develop-
ment ofairway symptoms.
What IstheMissingFactor?
Immunopathologic studies from many
laboratories suggest that the ultimate
development of chronic BHR is the result
ofrepeated cycles ofinflammatory damage
in the tissue (10). The initial trigger for
this process among atopics is allergen-
specific Th2 responses, but clearly other
additive/synergistic factors are required for
disease expression.
An increasing body ofevidence suggests
that environmental factors capable of
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Figure 1. Immunologic processes underlying the induction and expression of allergic respiratory disease-the potential role of ,B-glucan and other microbial associated factors.
Abbreviations: LPS, lipopolysaccharide; Th, T helper.
modifying immunoinflammatory processes
at the level ofthe airway mucosa or oftrig-
gering local inflammation directly may
play a key role in this context.
WorkingModel
The scheme in Figure 1 provides aworking
hypothesis for this overall process. Weakly
primed fetal Th2 responses are normally
immune-deviated postnatally to protective
ThI immunity, but a subset ofchildren (in
our experience, up to 35%) are at risk
because instead they consolidate Th2
immunity against one or more inhalant
allergens. Of this at-risk group, only
1/4-1/3 ultimately develop chronic
wheeze, and it is hypothesized that the lat-
ter group receives additive/synergistic
inflammatory signals from nonallergen
sources in the environment, which further
stimulate local airway tissue damage to lev-
els above the threshold required to trigger
disease expression (BHR).
The best documented ofthese environ-
mental factors is respiratory virus infection,
which has been identified as a major trigger
for asthma exacerbation in subjects with
pre-existing atopy (11), particularly in
school children. Air pollution may also
play a role, although the effects are proba-
bly relatively minor except in extreme cir-
cumstances (12). Furthermore, microbial
cell wall constituents such as endotoxin
(13,14) and molds (14) interfere with cells
engaged in the inflammatory-immune
process. Molds are well-known antigens
and may also cause nonspecific inflamma-
tory response. In their cell walls they
contain (1-*3)-P-D-glucan with well-
known inflammatory and immunogenic
properties (15,16).
(1-*3)-4-D-glucan causes cell infiltra-
tion in lung tissue and a reduction of
antibody formation to an inhaled antigen
(17). In a mouse model, the normal
downregulation of the allergen-specific
IgE response was abrogated by glucan
exposure (18). Other studies have demon-
strated that exposure of inflammatory
cells to (1-*3)-P-D-glucan can trigger
secretion ofmediator molecules known to
influence immune responses (19).
Depending on the dose and timing of
the exposure, environmental agents could
exert effects on at least two levels, as illus-
trated in Figure 1.
Thl/Th2 Regulation during Th-cell
Memory Development. The postnatal
modulation of fetally primed Th-cell
responses to allergens is regulated princi-
pally by antigen-presenting cells (APCs) in
the airway mucosa such as macrophages
and dendritic cells. These express surface
receptors for ,B-glucan. The triggering of
these receptors is likely to influence a vari-
ety of their functions associated with aller-
gen uptake and processing (particularly
cytokine secretion), all ofwhich can modu-
late ensuing Th-cell responses. The influx
and efflux of local APCs is also regulated
by the intensity and frequency ofexposure
to local microbial stimuli (20).
Expression ofAllergen-Specific Th2
Responses in the Airway Mucosa. The
defining feature of atopic asthma is the
presence oflarge numbers ofactivated Th
cells in the airway mucosa. The activity of
these cells is in turn regulated by inductive
signals from local APCs and by their
secreted (cytokine) products. As indicated
above, co-exposure to ,B-glucan has the
potential to modulate the functions of
these APCs.
Recent studies from several laborato-
ries indicate that secreted products from
alveolar macrophages play a key role in
regulating the tonus ofimmunoinflamma-
tory responses in the airways (21,22).
Macrophages have specific receptors for
(1->3)-f3-D-glucan, and alterations in the
normal function of macrophages have
been found after exposure to (1--3)-j3-D-
glucan (23).
In summary, the nature of immune
responses to inhaled allergens during the
early postnatal period is now recognized as
a key factor in determining allergen
responder phenotype in later life. Airborne
environmental factors can potentially influ-
ence these responses. Exposure to mold
components has not previously been stud-
ied in detail in this context, but further
research in this area appears justified.
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